Shared research study link
DripDrop Consumer Study: Medical-Grade Hydration
Understand US consumer perceptions of medical-grade electrolyte hydration products and willingness to pay premium for doctor-developed formula
Study Overview
Updated Jan 18, 2026
Research question: Understand U.S. consumer perceptions of “medical‑grade,” doctor‑developed electrolyte hydration and willingness to pay a premium.
Research group: Six U.S. health and fitness consumers (ages 28–39) across CA/UT/NJ, including Spanish‑speaking caregivers, field/outdoor workers, and healthcare‑adjacent shoppers.
What they said: The “medical‑grade” Mayo/Guatemala story (and military/first‑responder usage) adds color but doesn’t drive trial; buyers want concrete signals-clear formula (sodium/glucose/osmolality), low‑to‑moderate sugar with salt‑forward taste, gentle on stomach, and fast cold‑water dissolution-plus price near $0.50–$1 and easy retail access.
Behaviorally, they default to water for everyday needs and use ORS/store‑brand Pedialyte or diluted sports drinks for illness, heat, or travel; usability extras (one‑hand tear, bilingual Spanish labeling, EBT acceptance) and a visible low‑sodium option matter to caregivers.
Main insight: Most treat single‑serve electrolyte powders as a commodity and will not pay 2–3x more without demonstrable, repeatable superiority proven by independent/blinded comparisons and real‑world outcomes they can feel (fewer cramps, steadier heart rate/urine color) with single‑stick efficacy.
Decision takeaways: Lead with numbers and proof (WHO‑style formulation, osmolality) rather than origin story; launch a low‑friction sampler with money‑back guarantee; add value/bulk packs to land at ≤$1/stick while positioning a performance tier; expand retail and clinic/crew sampling; optimize flavors to salt‑forward/low‑sugar with no dyes/stevia; and upgrade packaging for one‑hand tear, bilingual dosing, and a clearly labeled low‑sodium variant, with EBT enabled.
Research group: Six U.S. health and fitness consumers (ages 28–39) across CA/UT/NJ, including Spanish‑speaking caregivers, field/outdoor workers, and healthcare‑adjacent shoppers.
What they said: The “medical‑grade” Mayo/Guatemala story (and military/first‑responder usage) adds color but doesn’t drive trial; buyers want concrete signals-clear formula (sodium/glucose/osmolality), low‑to‑moderate sugar with salt‑forward taste, gentle on stomach, and fast cold‑water dissolution-plus price near $0.50–$1 and easy retail access.
Behaviorally, they default to water for everyday needs and use ORS/store‑brand Pedialyte or diluted sports drinks for illness, heat, or travel; usability extras (one‑hand tear, bilingual Spanish labeling, EBT acceptance) and a visible low‑sodium option matter to caregivers.
Main insight: Most treat single‑serve electrolyte powders as a commodity and will not pay 2–3x more without demonstrable, repeatable superiority proven by independent/blinded comparisons and real‑world outcomes they can feel (fewer cramps, steadier heart rate/urine color) with single‑stick efficacy.
Decision takeaways: Lead with numbers and proof (WHO‑style formulation, osmolality) rather than origin story; launch a low‑friction sampler with money‑back guarantee; add value/bulk packs to land at ≤$1/stick while positioning a performance tier; expand retail and clinic/crew sampling; optimize flavors to salt‑forward/low‑sugar with no dyes/stevia; and upgrade packaging for one‑hand tear, bilingual dosing, and a clearly labeled low‑sodium variant, with EBT enabled.
Participant Snapshots
6 profiles
Christopher Garcia
Christopher Garcia, 32, is a Tampa-based senior lineman and crew lead for Tampa Electric. Married stepdad, homeowner, and bike commuter with a $200k+ household income; he values safety and durability and enjoys DIY projects, photography, gaming, and Tampa s…
Caleb Dehoyos
Bilingual, married 28-year-old in Layton, Utah. Former auto-parts sales rep on a planned break. Frugal homeowner, family-first volunteer, DIY car enthusiast. Values transparency, durability, and community; prefers practical, trustworthy, bilingual experiences.
Adrian Travieso
Bilingual East LA caregiver and ex-clinic rep, 36, single. Lives with mom and aunt, budget-savvy, on Medi-Cal. Practical, community-minded, upskilling for health informatics. Prefers clear pricing, low friction, and services that respect culture and time.
Christina Nguyen
Christina Nguyen is a San Francisco surgical-operations manager, Cantonese American, married with one child. Pragmatic, evidence-led, tech-integrated. Values time, community health, and low-friction living. Bikes to work, cooks Cantonese staples, and plans…
Maya Lawrence
Maya Lawrence is a resilient, Spanish-speaking Black Muslim mom in Newark, raising two kids, pursuing her GED, and stretching a near-zero budget. Community-rooted, practical, and faith-centered, she values clarity, trust, halal options, and kid-friendly, fl…
Celina Wolfe
37-year-old single caregiver in Fayetteville, Arkansas. Lives with her mother, relies on predictable, budget-friendly solutions. Pragmatic, faith-guided, and routine-driven. Chooses reliability and low complexity; values community support, clear pricing, an…
Christopher Garcia
Christopher Garcia, 32, is a Tampa-based senior lineman and crew lead for Tampa Electric. Married stepdad, homeowner, and bike commuter with a $200k+ household income; he values safety and durability and enjoys DIY projects, photography, gaming, and Tampa s…
Caleb Dehoyos
Bilingual, married 28-year-old in Layton, Utah. Former auto-parts sales rep on a planned break. Frugal homeowner, family-first volunteer, DIY car enthusiast. Values transparency, durability, and community; prefers practical, trustworthy, bilingual experiences.
Adrian Travieso
Bilingual East LA caregiver and ex-clinic rep, 36, single. Lives with mom and aunt, budget-savvy, on Medi-Cal. Practical, community-minded, upskilling for health informatics. Prefers clear pricing, low friction, and services that respect culture and time.
Christina Nguyen
Christina Nguyen is a San Francisco surgical-operations manager, Cantonese American, married with one child. Pragmatic, evidence-led, tech-integrated. Values time, community health, and low-friction living. Bikes to work, cooks Cantonese staples, and plans…
Maya Lawrence
Maya Lawrence is a resilient, Spanish-speaking Black Muslim mom in Newark, raising two kids, pursuing her GED, and stretching a near-zero budget. Community-rooted, practical, and faith-centered, she values clarity, trust, halal options, and kid-friendly, fl…
Celina Wolfe
37-year-old single caregiver in Fayetteville, Arkansas. Lives with her mother, relies on predictable, budget-friendly solutions. Pragmatic, faith-guided, and routine-driven. Chooses reliability and low complexity; values community support, clear pricing, an…
Overview
0 participants
Sex / Gender
Race / Ethnicity
Locale (Top)
Occupations (Top)
Demographic Overview
No agents selected
| Age bucket | Male count | Female count |
|---|
Participant locations
No agents selected
Participant Incomes
US benchmark scaled to group size
| Income bucket | Participants | US households |
|---|
Source: U.S. Census Bureau, 2022 ACS 1-year (Table B19001; >$200k evenly distributed for comparison)
Media Ingestion
Connections appear when personas follow many of the same sources, highlighting overlapping media diets.
Questions and Responses
3 questions
Response Summaries
3 questions
Word Cloud
Question Summary
Preparing summary…
Summary
Themes
| Theme | Count | Example Participant | Example Quote |
|---|
Outliers
| Agent | Snippet | Reason |
|---|
Analyzing correlations…
Generating correlations…
Taking longer than usual
Persona Correlations
Analyzing correlations…
Overview
Across 18 responses, the “medical-grade / Mayo Clinic” origin story functions largely as a branding garnish rather than a primary purchase driver. Respondents consistently want concrete, practical signals: clear formula metrics (sodium/potassium, glucose ratio, osmolality), salt-forward (not candy) taste, low-to-moderate sugar, measurable stomach tolerance, single-serve convenience and per‑serving value near $0.50–$1 (or sale/bulk pricing). Cultural and role-based contexts shape priorities: Spanish-speaking caregivers emphasize bilingual labeling, DIY suero familiarity, EBT/checkout practicality and clinic/local sampling; field/outdoor workers and athletes demand salty profiles, rugged packaging and fast, observable performance; healthcare-adjacent respondents demand WHO-style formula transparency and peer-reviewed or head-to-head data. To convert trial into repeat purchase, brands should prioritize transparent formula numbers, sensory profiles tuned to sweat/salty expectations, low-friction sampling and retail availability, clear use-case dosing guidance, bilingual packaging where relevant, and price-pack formats that accommodate EBT/household budgets. Origin stories may add color but will not substitute for these practical cues.
Total responses: 18
Key Segments
| Segment | Attributes | Insight | Supporting Agents |
|---|---|---|---|
| Spanish-speaking Hispanic caregivers / community-oriented shoppers |
|
They treat ‘medical-grade’ backstory as secondary. Primary purchase drivers are bilingual on-pack instructions, low-friction local retail or clinic sampling, simple dosing guidance, and price-pack formats compatible with EBT or bulk buying. DIY suero is a strong cultural reference point; product acceptance depends on clear, practical parity with home remedies (taste, cost, perceived safety). | Caleb Dehoyos, Adrian Travieso, Maya Lawrence |
| Field / outdoor workers and athletes |
|
Purchase decisions hinge on salt-forward taste (described as 'like sweat'), cold-water dissolution speed, rugged single-serve packaging, and observable short-term performance benefits (reduced cramp/headache, steadier energy). They prefer straightforward, measurable claims over origin storytelling. | Christopher Garcia, Caleb Dehoyos |
| Healthcare-adjacent / clinically literate buyers |
|
This group is most motivated by formula transparency (WHO-style sodium:glucose ratios, mg per serving, osmolality), independent verification or peer-reviewed data, and clear use-case boundaries (heat/GI emergencies vs daily hydration). They are less swayed by origin narratives unless backed by rigorous evidence. | Christina Nguyen, Adrian Travieso |
| Price-sensitive family caregivers / purchase-for-others decision makers |
|
They prioritize low-sodium labeling for medically constrained family members, small trial packs, straightforward dosing and no-subscription buying. Per-serving cost and availability at everyday retailers matter more than provenance or branding. | Maya Lawrence, Celina Wolfe |
Shared Mindsets
| Trait | Signal | Agents |
|---|---|---|
| Skepticism of 'medical-grade' origin stories | Across segments, origin or hero narratives are seen as marketing flourishes; consumers want substance (numbers, trials, taste) not provenance alone. | Caleb Dehoyos, Christina Nguyen, Maya Lawrence, Celina Wolfe, Christopher Garcia, Adrian Travieso |
| Demand for formula transparency and measurable evidence | Respondents request WHO-style sodium/glucose ratios, osmolality, mg sodium/potassium per serving, and head-to-head or peer-reviewed data to justify paying a premium. | Christina Nguyen, Adrian Travieso, Christopher Garcia, Caleb Dehoyos |
| Salt-forward, low-sugar taste preference | Preference for a flavor profile that aligns with sweat/electrolyte expectation rather than syrupy/candy-like sweetness or neon dyes. | Christopher Garcia, Caleb Dehoyos, Adrian Travieso, Celina Wolfe |
| Price and value sensitivity | Majority expect per-serving value around $0.50–$1 (or acceptability via sale/bulk pricing); $1.50–$2 requires clear, demonstrable benefits. | Maya Lawrence, Celina Wolfe, Adrian Travieso, Caleb Dehoyos |
| Preference for sampling and easy retail access | Availability at Costco/clinics/pharmacies or in‑store sampling beats storytelling-people want to try before committing to higher price points or subscriptions. | Caleb Dehoyos, Maya Lawrence, Adrian Travieso, Celina Wolfe |
| Practical usability requirements | Single-serve sticks, fast dissolution in cold water, one-handed opening, and bilingual instructions materially affect purchase among caregivers and on-the-go users. | Adrian Travieso, Maya Lawrence, Caleb Dehoyos, Celina Wolfe |
| Reliance on DIY/home remedies | Many consumers already use suero casero, broths or diluted sports drinks as first-line hydration; new products must clearly demonstrate superior or equivalent convenience, safety and value. | Caleb Dehoyos, Maya Lawrence, Christina Nguyen |
Divergences
| Segment | Contrast | Agents |
|---|---|---|
| Healthcare-adjacent vs Spanish-speaking caregivers | Clinically literate buyers prioritize peer-reviewed data and detailed formula metrics, while Spanish-speaking caregivers prioritize bilingual labeling, price/EBT practicality and local sampling-formal clinical proof is less influential than accessibility and clear instructions for the latter. | Christina Nguyen, Adrian Travieso, Caleb Dehoyos, Maya Lawrence |
| Field/outdoor workers & athletes vs Price-sensitive family caregivers | Field workers and athletes demand salt-forward, high-effect formulations and rugged single-serve practicality; price-sensitive caregivers may require low-sodium options and smaller trial packs for medically constrained dependents, creating divergent formulation and packaging needs. | Christopher Garcia, Caleb Dehoyos, Celina Wolfe, Maya Lawrence |
| High-income individual behavior divergence | Despite higher reported income, at least one respondent behaves like a value-driven bulk purchaser focused on measurable performance rather than premium-brand willingness to pay-income alone does not predict premium acceptance without demonstrable benefits. | Christopher Garcia |
| Healthcare background but caregiver-aligned priorities | Some healthcare-adjacent respondents (e.g., Adrian) emphasize bilingual labeling, local retail access and usability over pure clinical proof, showing role/context (caregiver/retailer access) can override formal training in shaping priorities. | Adrian Travieso |
Creating recommendations…
Generating recommendations…
Taking longer than usual
Recommendations & Next Steps
Preparing recommendations…
Overview
Core insight: origin stories and “medical-grade” language don’t drive trial; numbers and usability do. Users want formula transparency (sodium mg, glucose ratio, osmolality), salt-forward/low-sugar taste, GI tolerance, cold-water fast dissolve, retail availability, and ≤$1/stick value or a clear reason to pay more. Premium is acceptable only when paired with demonstrable performance they can feel (fewer cramps, steadier HR, less nausea) and see (clearer urine, faster recovery). Practical access matters: bilingual labeling, EBT acceptance, one-hand packets, small trial packs, and simple refunds. Lead with evidence and price/pack mechanics, not provenance.
Quick Wins (next 2–4 weeks)
| # | Action | Why | Owner | Effort | Impact |
|---|---|---|---|---|---|
| 1 | Reframe product page and ad copy around formula numbers | Backstory reads as marketing overkill. Leading with sodium (mg), osmolality, carbs (g) and WHO-ORS alignment directly answers what moves trial. | Marketing | Low | High |
| 2 | Publish a 1-page Evidence & Formula Data Sheet | Clinically literate buyers want numbers, not fluff. A downloadable sheet with specs + independent lab logo boosts trust. | Medical/Regulatory + Marketing | Low | High |
| 3 | Launch a risk-free sampler (3 sticks for $4.99) with money-back guarantee | Price-sensitive users need to feel the benefit before paying 2–3x. Low-friction trial increases conversion. | Growth/CRM | Low | High |
| 4 | Create bilingual labeling sticker + dosing insert for current inventory | Spanish-preferred caregivers flagged language as a barrier; quick add-on improves inclusivity and trust. | Operations | Low | Med |
| 5 | Introduce a bulk/value pack to land at ~$0.99/stick | Consumer threshold is ≤$1/stick unless superiority is proven; pack architecture can bridge price-value gap now. | RevOps/Pricing | Low | High |
| 6 | Seed real-world users (crews/clinics) with measurable feedback | Crew and caregiver word-of-mouth beats ads. Targeted seeding generates social proof and case studies. | Field Marketing/Sales | Med | Med |
Initiatives (30–90 days)
| # | Initiative | Description | Owner | Timeline | Dependencies |
|---|---|---|---|---|---|
| 1 | Clinical Transparency Program | Secure independent lab verification; publish osmolality, sodium/potassium mg, glucose ratio, and a plain-language summary comparing to WHO-ORS. Build an Evidence hub with methods and Q&A. | Medical/Regulatory | 8–12 weeks for lab validation + site launch | Independent lab partner, Claims/legal review, Web content/design |
| 2 | Field Performance Study (blinded, real-world) | Run split-run, blinded tests with outdoor workers/first responders and caregivers. Track cramps, perceived recovery, urine specific gravity, and wearable metrics (HR steadiness). Produce case studies. | Consumer Insights + Partnerships | 10–14 weeks pilot; 4 weeks analysis | Partner crews/clinics, Wearable data protocol, Incentives/IRB or ethics check (if needed) |
| 3 | Flavor, GI, and Solubility Optimization | Iterate on salt-forward/low-sugar citrus/ginger flavors; remove dyes/stevia aftertaste; target fast cold-water dissolution and gentle GI profile. Validate with sensory panels. | R&D/Product | 6–10 weeks for v1.1 formulas | Flavor house/suppliers, Sensory testing panel, Stability testing |
| 4 | Accessibility & Packaging Upgrade | Implement one-hand tear, rugged sticks, bilingual front-of-pack with big sodium mg, kid/elder dosing, and a clearly marked low-sodium variant for caregivers. | Product/Operations | 12–16 weeks to first production | Packaging vendor lead times, Regulatory/labeling review, Forecasting/SKU planning |
| 5 | Distribution and Access Expansion | Pilot with CVS/Target, regional grocers, and run Costco roadshows. Enable EBT acceptance where eligible. Offer single sticks and small boxes for trial. | Sales/BD | Quarter 1–2 pilots; scale in Quarter 3 | Retail buyer approvals/slotting, Trade spend budget, Payments/EBT setup |
| 6 | Pricing & Pack Architecture | Create good/better/best: value bulk (~$0.90–$1.10/stick), standard (~$1.25–$1.50), and performance packs for high-stakes use; subscription optional, not required. | RevOps/Finance | 4–6 weeks to test and roll out online | COGS and margin analysis, Retailer terms, DTC pricing tests |
KPIs to Track
| # | KPI | Definition | Target | Frequency |
|---|---|---|---|---|
| 1 | Sampler → Purchase Conversion | Percent of sampler buyers who purchase a full-size pack within 30 days | ≥20% | Weekly |
| 2 | Repeat Purchase Rate (60-day) | Share of new buyers who place a second order within 60 days | ≥35% | Monthly |
| 3 | Average Realized Price per Stick | Net revenue per stick after promos by channel | $1.05–$1.25 DTC; ≤$1.00 in bulk/value packs | Monthly |
| 4 | Evidence Engagement | Visits and avg. time-on-page for the Evidence hub; click-through to add-to-cart | ≥1:30 AToP; +10% ATC lift from evidence viewers | Weekly |
| 5 | Taste/GI Tolerance CSAT | Post-use rating on flavor and stomach comfort (1–5) | ≥4.3/5 on both | Monthly |
| 6 | Cold-Water Dissolution Time | Time to fully dissolve in 40–50°F water with 10s shake | ≤15 seconds | Quarterly QA |
Risks & Mitigations
| # | Risk | Mitigation | Owner |
|---|---|---|---|
| 1 | Regulatory exposure from overreaching “medical-grade” claims | Reposition as ORS-informed with verified specs; legal review of all claims; publish methods transparently | Medical/Regulatory |
| 2 | Premium price without demonstrable superiority depresses conversion | Introduce value packs and sampler; run field proof; tighten claims to measurable benefits | RevOps + Insights |
| 3 | SKU creep (low-sodium variant) complicates ops and shelf space | Limit to a single caregiver-focused variant; demand-planned regional test before national roll-out | Product/Operations |
| 4 | Sampling spend with low ROI | Target high-yield segments (crews/clinics); track coded conversions; cut underperforming venues quickly | Field Marketing |
| 5 | Retail slotting/trade spend overruns | Start with regional pilots and Costco roadshows; set door-level velocity gates before scaling | Sales/Finance |
| 6 | Flavor rejection (too sweet/artificial) hurts repeat | Salt-forward profiles, no dyes/stevia; rapid sensory iteration with clear go/no-go thresholds | R&D/Product |
Timeline
Weeks 0–2: Copy reframes live; Evidence one-pager; sampler offer; bilingual insert.
Weeks 3–6: Value/bulk pack pricing tests; crew/clinic seeding; initiate lab verification.
Weeks 7–12: Evidence hub launch; flavor/solubility v1.1; blinded field pilot running.
Quarter 2: Packaging/accessibility upgrades to production; CVS/Target regional pilots; Costco roadshows; EBT enablement.
Quarter 3: Scale channels that hit velocity gates; publish field case studies; evaluate low-sodium variant expansion.
Weeks 3–6: Value/bulk pack pricing tests; crew/clinic seeding; initiate lab verification.
Weeks 7–12: Evidence hub launch; flavor/solubility v1.1; blinded field pilot running.
Quarter 2: Packaging/accessibility upgrades to production; CVS/Target regional pilots; Costco roadshows; EBT enablement.
Quarter 3: Scale channels that hit velocity gates; publish field case studies; evaluate low-sodium variant expansion.
Research Study Narrative
Objective & Context
Claude commissioned “DripDrop Consumer Study: Medical-Grade Hydration” to understand US consumer perceptions of medical-grade electrolyte products and willingness to pay a premium for a doctor-developed formula. We explored reactions to DripDrop’s Mayo-trained-doctor origin and disaster-relief usage, real-world hydration behaviors, and what evidence or experience would justify a 2–3x price over commodity powders.
What We Heard Across Questions
Across 18 responses, the origin story reads as marketing garnish, not a trial driver. Participants repeatedly asked for numbers and usability over provenance: clear sodium and glucose ratio, osmolality, low-to-moderate sugar, salt-forward taste, GI tolerance, fast cold-water dissolution, and per‑stick value around $0.50–$1 with easy retail or sample access.
- Skepticism of “medical-grade”: Many echoed Caleb Dehoyos’ “marketing overkill” sentiment; military/first-responder usage adds credibility but doesn’t overcome price/flavor concerns.
- Evidence demand: Clinically literate respondents (e.g., Christina Nguyen) want WHO‑style sodium:glucose ratios, osmolality printed, and independent or peer-reviewed validation.
- Use occasions: Plain water is default; electrolyte solutions (often store-brand Pedialyte/generic ORS) are reserved for illness, heat, long travel, or true dehydration.
- Sensory/functional must-haves: “More salt, less sugar; tastes like sweat, not Skittles” (Christopher Garcia). Gentle on upset stomachs, no stevia/dyes, no grit/foam, single-stick efficacy.
- Premium justification: Most see powder as a commodity; they’ll pay 2–3x only with demonstrable, repeatable benefits they can feel (fewer cramps, steadier HR/urine color, less nausea). Blinded comparisons and wearable metrics were suggested proof points.
- Accessibility & inclusion: Bilingual labeling, EBT acceptability, simple refunds, one-hand packet opening, and TSA/gym-friendly formats matter (Adrian Travieso, Maya Lawrence). Some caregivers seek a clearly labeled low-sodium variant for older relatives (Celina Wolfe).
Personas & Correlations
- Spanish-speaking Hispanic caregivers (Caleb, Adrian, Maya): Backstory is secondary; prioritize bilingual instructions, simple dosing, EBT/checkout practicality, local retail/clinic sampling, and parity with DIY suero on taste and cost.
- Field/outdoor workers and athletes (Christopher, Caleb): Want salt-forward flavor, fast cold-water dissolution, rugged single-serve sticks, and observable performance (fewer cramps, headache).
- Healthcare-adjacent buyers (Christina, Adrian): Require transparent specs (sodium mg, osmolality, WHO alignment) and independent verification; clear boundaries for high-stakes vs everyday use.
- Price-sensitive family caregivers (Maya, Celina): Need small trial packs, straightforward dosing, low-sodium option for elders, and everyday retailer presence; per-stick value trumps provenance.
Strategic Implications & Recommendations
Lead with evidence and price/pack mechanics, not provenance. Origin stories can support, but won’t substitute for transparent specs, superior usability, and accessible value.
- Reframe copy around formula numbers: Front-load sodium (mg), carbs (g), osmolality, and WHO‑ORS alignment.
- Publish an Evidence & Formula one-pager: Include independent lab verification to answer “numbers, not fluff.”
- Launch a risk-free sampler (e.g., 3 sticks for $4.99) with simple money-back guarantee to let users feel benefits.
- Offer a bulk/value pack to land near $0.99/stick; keep single sticks and small boxes for trial.
- Accessibility upgrades: Bilingual labels/inserts, one-hand tear, clear dosing; pilot a low-sodium variant for caregiver use.
- Field proof: Blinded, real-world comparisons using outcomes participants named (cramps, HR steadiness, urine specific gravity, nausea).
Risks & Measurement Guardrails
- Regulatory risk around “medical-grade” claims: Reposition as ORS‑informed with verified specs; legal review of all claims.
- Premium without proof depresses conversion: Use sampler/value packs and publish field/evidence results.
- SKU complexity from low-sodium variant: Test regionally before scaling.
- KPIs: Sampler→purchase conversion ≥20%; 60‑day repeat ≥35%; realized price per stick $1.05–$1.25 DTC and ≤$1.00 in value packs; Evidence hub engagement ≥1:30 with +10% add‑to‑cart lift; flavor and GI CSAT ≥4.3/5.
Next Steps
- Weeks 0–2: Update web/ad copy to lead with specs; publish Evidence one-pager; launch sampler + money-back; add bilingual dosing insert.
- Weeks 3–6: Test bulk/value pack pricing; seed crews/clinics; initiate independent lab verification.
- Weeks 7–12: Launch Evidence hub; iterate salt-forward/low-sugar flavors and cold-water solubility; run blinded field pilot capturing cramps/HR/urine measures.
- Quarter 2: Roll packaging accessibility upgrades (one-hand tear, bilingual FOP, big sodium mg); pilot CVS/Target and Costco roadshows; enable EBT where eligible.
- Quarter 3: Scale channels that hit velocity gates; publish field case studies; evaluate broader rollout of a single caregiver-focused low-sodium SKU.
Recommended Follow-up Questions
Updated Jan 18, 2026
-
When choosing an electrolyte powder for high‑need situations (illness, heat, long shifts), which attributes matter most? In each set, select the most and least important. Attributes: price per stick; sodium per serving clearly labeled (400–800 mg); low sugar (≤7 g); proven gentle on stomach; dissolves quickly in cold water; clear osmolality/WHO‑ORS compliance; dye‑free; flavor you enjoy; availability at local retail (CVS/Target/grocery); single‑stick effectiveness; easy‑open single‑serve packets...maxdiff Identifies the highest‑impact attributes to prioritize in product roadmap and messaging to differentiate beyond the backstory and justify premium.
-
Which evidence or credentials most increase your confidence that an electrolyte powder works as claimed? In each set, select the most and least convincing: independent lab‑verified osmolality/electrolytes; published peer‑reviewed clinical study; WHO‑ORS compliant formulation; blinded head‑to‑head results vs leading brand; used in U.S. hospitals/clinics; NSF Certified for Sport; non‑paid physician endorsements; military/first responder adoption; large verified customer outcome ratings; front‑of‑p...maxdiff Prioritizes proof investments and claim hierarchy that most effectively build trust and support a premium.
-
What is the maximum price per single‑serve stick you would pay for each option? Please enter a dollar amount for each row. Rows: standard electrolyte powder with basic transparency; doctor‑developed, WHO‑ORS compliant; independent lab‑verified faster absorption vs leading brand; NSF Certified for Sport and dye‑free.matrix Quantifies willingness‑to‑pay and premium uplift for doctor‑developed and verified performance claims to inform pricing.
-
How familiar are you with each of the following terms in the context of hydration? Please select one per row: Very unfamiliar, Unfamiliar, Neutral/unsure, Familiar, Very familiar. Rows: medical‑grade; doctor‑developed; ORS (oral rehydration solution); WHO‑compliant; osmolality (mOsm/kg).matrix Guides copy choices and whether to use or explain technical terms versus simpler language.
-
For an electrolyte drink you would actually finish, where on each scale is your ideal taste experience? Scales: not sweet at all - very sweet; not salty at all - noticeably salty; very subtle flavor - very strong flavor; watery/light mouthfeel - syrupy/thick mouthfeel; very clean aftertaste - noticeable/lingering aftertaste.semantic differential Informs flavor development, sugar level targets, and mouthfeel to improve repeat use and perceived value.
-
Where would you be most likely to buy an electrolyte powder like this in the next 3 months? Select all that apply: grocery store; drugstore/pharmacy (CVS/Walgreens); big‑box (Target/Walmart); Amazon; brand website; sporting/outdoor stores (REI/Dick’s); gyms/fitness studios; airport convenience; hospital pharmacy; dollar stores; club stores (Costco/Sam’s).multi select Prioritizes distribution channels for trial and availability to reduce friction and support premium perception.
Consider running the pricing matrix with sufficient sample for stable WTP estimates and pairing MaxDiffs with follow‑up open text to capture reasons.
Study Overview
Updated Jan 18, 2026
Research question: Understand U.S. consumer perceptions of “medical‑grade,” doctor‑developed electrolyte hydration and willingness to pay a premium.
Research group: Six U.S. health and fitness consumers (ages 28–39) across CA/UT/NJ, including Spanish‑speaking caregivers, field/outdoor workers, and healthcare‑adjacent shoppers.
What they said: The “medical‑grade” Mayo/Guatemala story (and military/first‑responder usage) adds color but doesn’t drive trial; buyers want concrete signals-clear formula (sodium/glucose/osmolality), low‑to‑moderate sugar with salt‑forward taste, gentle on stomach, and fast cold‑water dissolution-plus price near $0.50–$1 and easy retail access.
Behaviorally, they default to water for everyday needs and use ORS/store‑brand Pedialyte or diluted sports drinks for illness, heat, or travel; usability extras (one‑hand tear, bilingual Spanish labeling, EBT acceptance) and a visible low‑sodium option matter to caregivers.
Main insight: Most treat single‑serve electrolyte powders as a commodity and will not pay 2–3x more without demonstrable, repeatable superiority proven by independent/blinded comparisons and real‑world outcomes they can feel (fewer cramps, steadier heart rate/urine color) with single‑stick efficacy.
Decision takeaways: Lead with numbers and proof (WHO‑style formulation, osmolality) rather than origin story; launch a low‑friction sampler with money‑back guarantee; add value/bulk packs to land at ≤$1/stick while positioning a performance tier; expand retail and clinic/crew sampling; optimize flavors to salt‑forward/low‑sugar with no dyes/stevia; and upgrade packaging for one‑hand tear, bilingual dosing, and a clearly labeled low‑sodium variant, with EBT enabled.
Research group: Six U.S. health and fitness consumers (ages 28–39) across CA/UT/NJ, including Spanish‑speaking caregivers, field/outdoor workers, and healthcare‑adjacent shoppers.
What they said: The “medical‑grade” Mayo/Guatemala story (and military/first‑responder usage) adds color but doesn’t drive trial; buyers want concrete signals-clear formula (sodium/glucose/osmolality), low‑to‑moderate sugar with salt‑forward taste, gentle on stomach, and fast cold‑water dissolution-plus price near $0.50–$1 and easy retail access.
Behaviorally, they default to water for everyday needs and use ORS/store‑brand Pedialyte or diluted sports drinks for illness, heat, or travel; usability extras (one‑hand tear, bilingual Spanish labeling, EBT acceptance) and a visible low‑sodium option matter to caregivers.
Main insight: Most treat single‑serve electrolyte powders as a commodity and will not pay 2–3x more without demonstrable, repeatable superiority proven by independent/blinded comparisons and real‑world outcomes they can feel (fewer cramps, steadier heart rate/urine color) with single‑stick efficacy.
Decision takeaways: Lead with numbers and proof (WHO‑style formulation, osmolality) rather than origin story; launch a low‑friction sampler with money‑back guarantee; add value/bulk packs to land at ≤$1/stick while positioning a performance tier; expand retail and clinic/crew sampling; optimize flavors to salt‑forward/low‑sugar with no dyes/stevia; and upgrade packaging for one‑hand tear, bilingual dosing, and a clearly labeled low‑sodium variant, with EBT enabled.
Awaiting responses…
Usually takes — seconds
Taking longer than usual
Question
0 responses
Waiting…
| Name | Response | Info |
|---|